Efficacy of subgroup mouse bone mesenchymal stem cells on mobilizing autologous cardiac stem cells and repairing ischemic myocardial tissue

Chinese Journal of Cardiology

Volumn 41, Issue 3, 2013, Pages 210-214

  He, Ji Gang ^a   Shen, Zhen Ya ^a   Teng, Xiao Mei ^a   Yu, Yun Sheng ^a   Huang, Hao Yue ^a   Ye, Wen Xue ^a   Ding, Ying Long ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Mesenchymal stem cell transplantation; Myocardial infarction

Indexed keywords

ATAXIN 1; CD31 ANTIGEN; CD45 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ARTICLE; CELL DIFFERENTIATION; CELL SELECTION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION;

EID: 84876798989     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2013.03.008     Document Type: Article

References (12)

1. Torella D, Indolfi C, Goldspink D F, et al. Cardiac stem cell-based myocardial regenration: towards a translational approach. Cardiovasc Hematol Agents Med Chem, 2008, 6: 53-59.
2. Biswas S, Charlesworth P J, Turner G D, et al. CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. Carcinogenesis, 2012, 33: 1717-1725.
3. Roberts J L, Buckley R H, Luo B, et al. CD45-deficient severe combined immunodeficiency caused by uniparental disomy. PNAS, 2012, 109:10456-10461.
4. Nagaya N, Kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 2005, 112: 1128-1135.
5. Kanemitsu N, Tambara K, Premaratne G U, et al. Insulin-like growth factor-1 enhances the efficacy of myoblast transplantation with its multiple functions in the chronic myocardial infarction rat model. J Heart Lung Transplant, 2006, 25:1253-1262.
6. Brunet A, Bonni A, Zigmond M J, et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell, 2009, 96:857-868.
7. Salem H K, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, 2010, 28:585-596.
8. Boyle A J, Schulman S P, Hare J M, et al. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step. Circulation, 2006, 114:339-352.
9. Fedak P W, Weisel R D, Verma S, et al. Restoration and regeneration of failing myocardium with cell transplantation and tissue engineering. Semin Thorac Cardiovasc Surg, 2003, 15:277-286.
10. Hatzistergos K E, Quevedo H, Oskouei B N, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res, 2010, 107:913-922.
11. 2011, 39: 1033-1038.
12. 2011, 39:171-175.